The Extreme Significance of Bilateral Embolic Retinal Phenomena That Can be Life Saving
NCT ID: NCT03078387
Last Updated: 2019-04-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2 participants
OBSERVATIONAL
2006-08-31
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Novel Clinical Utility of Retinal Imaging in Patients With Heart Failure
NCT05086978
Multimodal Retinal Imaging of Cerebrovascular Stroke
NCT03964610
Retina Microvascularisation and Cardiovascular Heart Disease Prediction
NCT01027988
REtinaL Imaging & Ambulatory BLood PrEssure
NCT04118205
Digital Ocular Fundus Photography in the Emergency Department: A New Application for Telemedicine?
NCT00873613
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The second case did not have general symptoms other than mild evening chills and her eye examination again was the start point of intensive investigation to find the reason of her bilateral retinal emboli. Ultrasound studies revealed a life threatening reason that was urgently treated.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
imaging
imaging before and after treatment
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
30 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dr. Shawkat Michel
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Shawkat Michel
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
shawkat s. Michel, MD, FRCS Ed
Role: PRINCIPAL_INVESTIGATOR
Dr. S.S. Michel Clinic, 214 MHC, 156 street and 87 Ave, Edmonton, AB, Canada
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dr. S.S. Michel Clinic
Edmonton, Alberta, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Bilateral retinal emboli
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.